Attorney General Kathy Jennings yesterday joined a coalition of 22 states and the District of Columbia in urging the U.S. Supreme Court to stay a ruling by the U.S. Court of Appeals for the Fifth Circuit that would restrict access to mifepristone, a safe and effective abortion medication. Shortly after, the U.S. Supreme Court entered an administrative stay, granting a one-week pause of the order. The Fifth Circuit ruling would reinstate a medically unnecessary in-person dispensing requirement for mifepristone, which can be safely provided through telehealth. In the amicus brief filed with the Supreme Court, Attorney General Jennings and the coalition argued that the Fifth Circuit’s ruling is not supported by law or science, would create regulatory and administrative chaos nationwide, and would interfere with states’ ability to protect access to reproductive health care within their borders, particularly in rural and medically-underserved areas. In February 2026, while the case was pending in the district court, Attorney General Jennings joined a multistate amicus brief to support the availability of mifepristone via telehealth.

“There is no reason whatsoever to restrict access to a medicine that is demonstrably safe, effective, and necessary for reproductive healthcare,” said Attorney General Kathy Jennings. “The Fifth Circuit’s ruling is a fig leaf for an extreme ideological crusade against the right to choose. This is a dangerous ruling that the Supreme Court must not allow to stand.”

Mifepristone, when used in combination with misoprostol, is the standard medication used to terminate a pregnancy through 10 weeks. Since the U.S. Food and Drug Administration (FDA) approved mifepristone in 2000, an estimated 7.5 million people in the United States have used the medication safely. Medication abortion now accounts for 63 percent of all abortions in the formal U.S. health care system, with approximately one in four abortions provided via telehealth. Studies have consistently found mifepristone to be safe and effective.

In 2023, after extensive review, the FDA eliminated the in-person dispensing requirement for mifepristone as medically unnecessary. That decision followed years of evidence, including during the COVID-19 pandemic, showing that mifepristone could be safely provided without requiring patients to appear in person. The FDA’s action allowed providers to offer mifepristone through telehealth and enabled patients to obtain the medication through certified mail-order pharmacies and other approved channels, expanding access for patients who face significant barriers to in-person care.

Attorney General Jennings and the coalition argued that reinstating the in-person dispensing requirement would curtail telehealth access to mifepristone, forcing patients to rely on more difficult alternatives or travel for in-person care. Telehealth has become an increasingly important way for patients in Delaware to access abortion care, with the nationwide share of abortions provided through telemedicine growing from five percent in 2022 to 27 percent in 2025.

The attorneys general also argued that the ruling would disrupt care in states like Delaware, where abortion remains legal and protected. Since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, clinics in states that protect abortion access have faced increased demand from both in-state and out-of-state patients. Forcing more patients to seek in-person care would place new strain on clinics and health care systems that are already stretched.

Attorney General Jennings and the coalition asserted that the Fifth Circuit’s ruling undermines states’ sovereign authority to protect and expand access to reproductive health care. In the wake of the Supreme Court’s Dobbs decision, which eliminated the federal constitutional right to abortion and returned regulation of abortion to the states, many states took swift executive and legislative action to safeguard reproductive rights and expand access to medication abortion. The attorneys general argued that courts cannot leverage medically unnecessary federal drug regulations to override those state policy choices or impose unnecessary barriers to care in states where abortion is legal.

Joining Attorney General Jennings in today’s coalition are the attorneys general of Arizona, California, Colorado, Connecticut, Hawaii, Illinois, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, New York, North Carolina, Oregon, Rhode Island, Vermont, Virginia, Washington, and the District of Columbia, as well as the Governor of Pennsylvania.

Delaware Attorney General Kathy Jennings has announced that a federal court will approve a $700 million settlement in a multistate antitrust lawsuit against Google. The lawsuit, first filed in 2021 by a bipartisan group of 52 Attorneys General, challenged Google’s control over Android app distribution and in-app payments. The approval of the settlement ends a five-year case and secures relief for consumers nationwide who were affected by Google’s actions.

The majority of the settlement funds will go directly to those who made purchases on Google Play between August 2016 and September 2023. Most recipients won’t need to fill out a claim form and will receive their payments through PayPal or Venmo.

If consumers don’t have access to PayPal or Venmo, they can file a claim through a separate process to receive their payment.

“For years, Google used its market dominance to establish a monopoly and take advantage of their customers,” said Attorney General Kathy Jennings. “With this settlement, consumers will finally get the compensation that they’re entitled to.”

The settlement forces Google to update its business practices. For at least the next five years, app developers may use alternate payment systems, inform customers about lower prices outside Google’s billing system, and list their apps on competing stores without fear of retaliation. Android users can download apps from outside the Play Store for at least the next seven years. Additional information about the lawsuit and settlement is available on the settlement website.

AG Jennings joined this effort alongside the attorneys general of: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands.

WILMINGTON – Attorney General Kathy Jennings today announced that a $7.4 billion settlement reached with Purdue Pharma and its owners, the Sackler family, has become legally effective, capping nearly a decade of work by her office and attorneys general from across the country in pursuing investigations and litigation over Purdue’s and the Sacklers’ role in fueling the opioid crisis. Delaware was among the first states to sue Purdue, when former Attorney General Matthew Denn initially filed suit. in 2018.  Attorney General Jennings then sued the Sackler family in 2019.   

After Purdue filed bankruptcy in September 2019 in light of massive litigation against it, the attorneys general have taken a lead role in the bankruptcy proceedings.  Jennings and the Delaware DOJ’s negotiating team were instrumental in securing the multibillion settlement, including helping achieve a new settlement that obtained more money from the Sacklers after the Supreme Court in June 2024 invalidated provisions in a prior settlement. The settlement gives funds to communities across the country, as well as individual victims and other groups who filed claims in the bankruptcy proceedings. The settlement also permanently bars the Sacklers from selling opioids in the United States.

“Delaware was hit harder by the opioid crisis than nearly any other state, and the Sacklers cast a very long shadow over that devastation,” said AG Jennings. “These funds allow us to continue driving overdose fatalities down, and I am grateful for the people who are doing that lifesaving work. But we would give back every penny to undo the loss that millions of American families, and thousands across Delaware, have suffered. This is a sad and ugly chapter in our history.”

Fifty-five attorneys general representing all eligible U.S. states and territories previously signed onto the settlement. It resolves litigation against Purdue and the Sacklers for producing and aggressively marketing opioids in the United States, fueling the largest drug crisis in the country’s history.

Delaware will receive over $27 million from the settlement, which will be deposited into Delaware’s Prescription Opioid Settlement Fund. While most states will receive payments over 15 years, Delaware will receive its share as a lump sum payment shortly after the settlement is finalized.  AG Jennings’ efforts in extended negotiations previously helped increase the Sacklers’ payment to the states by $1 billion; her role in subsequent negotiations resulted in Delaware receiving the full economic benefit of its 2022 settlement in one upfront payment, rather than in deferred payments over the course of 15 years.

This settlement agreement replaced a prior multistate agreement that the United States Supreme Court overturned in June 2024. That prior settlement, which included up to a $6 billion contribution from the Sacklers, was also achieved due in substantial part to the advocacy of AG Jennings and a handful of other states that had objected to the $4.5 billion Sackler contribution initially approved by the Bankruptcy Court. The final settlement included a greater financial contribution from the Sacklers, preserved the economic benefit of Delaware’s prior deal, and further broadened the availability of additional monetary relief to all participating states. In total, Delaware has secured roughly a quarter-billion dollars in opioid settlement funds.

The settlement also means that Purdue’s manufacturing operations transfer effective today to Knoa Pharma LLC, which will be overseen by a board of directors who had no connection to Purdue. The settlement prevents Knoa from marketing opioids and provides for an independent monitor to ensure it provides these medicines in the safest possible manner that limits the risk of diversion.

The settlement also provides Purdue and the Sacklers will make public more than 30 million documents related to their opioid business.

Attorney General Jennings is joined in reaching the settlement by Attorneys General of Alabama, Alaska, American Samoa, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Guam, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Ohio, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, U.S. Virgin Islands, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.

A Newark man has pled guilty in the 2024 Murder of Tracy Nyariki.  

On April 29, 2026, Nobert Matara, 33, pled guilty to Murder 1st Degree in New Castle County Superior Court. The plea follows an investigation into the December 2024 murder of 33-year-old Tracy Nyariki.

“The facts of this case are beyond disturbing,” said Attorney General Kathy Jennings. “It is difficult to comprehend this kind of violence. I am deeply grateful to our team and to the New Castle County Police who have worked tirelessly to achieve justice for the victim and her family. May it bring them some measure of peace.”

“I’m thankful for the hard work of our officers and detectives at the New Castle County Police Department, along with everyone at the Delaware Department of Justice, who carefully investigated this horrific incident,” said New Castle County Police Chief Col. James J. Leonard III. “Their commitment to justice and attention to detail were instrumental in securing this plea agreement.”

On December 17, 2024, Nobert Matara lay in wait at the Newark home of his ex-girlfriend, Tracy Nyariki. When she arrived a few hours later, he attacked her, stabbing her 58 times, dismembering her, and placing her body in a suitcase. He then fled to Aberdeen, Maryland where he was found at a motel with Tracy’s body in the trunk of his car.

Matara will be sentenced at a date to be determined and faces a mandatory life sentence.

Attorney General Kathy Jennings and a coalition of attorneys general have formalized an agreement to prevent the Trump Administration from distributing thousands of machine gun conversion devices into Delaware and other 16 other states.

In a notice of voluntary dismissal filed Friday, a coalition of AGs co-led by Delaware, New Jersey, and Maryland closed an earlier lawsuit against the Trump Administration—and in particular the Bureau of Alcohol, Tobacco, Firearms, and Explosives (ATF) , the U.S. Department of Justice, and several manufacturers and sellers of forced reset triggers (FRTs)—after securing the defendants’ agreement not to return or sell thousands of seized FRTs in the coalition states, where they are illegal. FRTs dramatically increase firearms rate of fire and allow even novice shooters to attain the firepower of a military machine gun.

“This is a seismic public safety win for Delaware and for all of the states in this coalition,” said Attorney General Kathy Jennings. “The federal government didn’t just abdicate its law enforcement responsibility to police these devices—it was prepared to actively flood our communities with weapons of war capable of firing hundreds of bullets per minute. They would have killed innocent people, period. This lawsuit stopped them. I’m grateful to our sister states and their teams who helped prevent catastrophe in our neighborhoods.”

The coalition filed their initial Complaint on June 9, 2025, followed by a Motion for Preliminary Injunction on June 10 and an Amended Complaint on July 7. In response, the federal defendants and defendants associated with the only FRT manufacturer to whom the ATF had returned FRTs, Rare Breed Triggers, LLC (“the RBT Defendants”), provided a sworn statement to the Court committing not to return FRTs into the plaintiff states and offering FRT owners in those states three options:

1. FRT owners may request that ATF transfer the device to them in a state where it is legal to possess.
2. FRT owners may request that ATF transfer the device to a third party in a state where it is legal to possess
3. FRT owners may withdraw the request for the return and abandon the device to ATF, in which case ATF would destroy the abandoned property without compensation and in accordance with federal law.

Under options 1 and 2, the FRT must remain in a state where the devices are legal. It is illegal to possess FRTs in Delaware or to transport FRTs into Delaware. Violations range from misdemeanors punishable from 6 months in prison and/or a $1,150 fine for a first offender, up to Class E felonies punishable by up to 5 years in prison for repeat offenders.

The Federal Defendants have since provided information confirming that the ATF is nearing completion of the returns and has adhered to the commitments it made in response to Motion for Preliminary Injunction and is drawing its return efforts to a close. The Federal Defendants have not returned FRTs to any Defendants other than the RBT Defendants. The RBT Defendants have not sold or returned FRTs into Delaware since providing their sworn statement, and their website states they do not ship FRTs into Delaware or any of the plaintiff states. AG Jennings and the coalition have agreed to dismiss this action without prejudice, reserving the right to file a new action challenging any attempt by Defendants to return or distribute FRTs into Plaintiff States.

In recent years, machine gun conversion devices (MCDs) have frequently been used in violent crimes and mass shootings, worsening the gun violence epidemic. Firearms equipped with these devices are able to approach or even exceed the rate of fire of many military machine guns, firing up to 20 bullets in one second. ATF has noted a significant rise in the use of MCDs, leading to increasing incidents of machine gun fire – up 1,400% from 2019 through 2021.

AG Jennings co-led this lawsuit together with the attorneys general of New Jersey and Maryland. They were joined by the attorneys general of California, Colorado, Hawai’i, Illinois, Maine, Massachusetts, Michigan, Minnesota, Nevada, Oregon, Rhode Island, Vermont, Washington and the District of Columbia.